Depression matters because it affects nearly every system in the body, shortens lives, and ranks among the top ten causes of disability worldwide. Approximately 332 million people globally have depression, and the condition costs an estimated $1 trillion per year in lost workplace productivity alone. Yet its significance extends far beyond those numbers. Depression reshapes the brain, drives up the risk of heart disease, makes other chronic illnesses harder to manage, and remains one of the strongest risk factors for suicide.
The Scale of the Problem
About 5.7% of adults worldwide experience depression at any given time, with women affected roughly 1.5 times more often than men (6.9% of women compared to 4.6% of men). More than 10% of pregnant women and new mothers experience it. Adults over 70 also face elevated rates, at about 5.9%. These numbers make depression one of the most common health conditions on the planet, yet it remains dramatically undertreated. Among people with diabetes and depression, for example, only 25% to 50% ever receive a diagnosis or treatment for the mood disorder.
Mental disorders as a group have remained among the top ten leading causes of health burden globally since at least 1990, with no evidence of meaningful reduction in three decades. Depression is a primary driver of that burden.
What Depression Does to the Brain
Depression is not simply feeling sad. Chronic episodes physically alter brain structure. Research on women with recurrent depression found that the hippocampus, a brain region central to memory and emotional regulation, was roughly 9 to 10% smaller than in people who had never been depressed. The amygdala, which processes fear and emotional responses, showed even greater shrinkage of about 12 to 13%.
These changes appear to be driven by prolonged exposure to stress hormones, which damage neurons over time. Depression also reduces levels of a key protein that protects and maintains brain cells, leaving neurons more vulnerable to further damage. The longer depression goes untreated, the more pronounced these structural changes become, which helps explain why early treatment matters so much.
Depression Raises Heart Disease Risk
One of the most consequential and underappreciated effects of depression is its link to cardiovascular disease. CDC data from a large national survey found that young women (ages 20 to 39) with major depression had a 59% higher prevalence of high lifetime cardiovascular risk compared to women without depression. For young men with major depression, that figure was 40% higher.
The relationship holds in older adults too. Among women aged 40 to 79, the ten-year risk of a cardiovascular event rose from 6.0% with no depression to 7.6% with major depression. For men in the same age range, it climbed from 9.9% to 11.3%. These aren’t trivial differences at a population level. When hundreds of millions of people have depression, even modest increases in heart disease risk translate into enormous numbers of heart attacks and strokes.
Chronic Inflammation and the Body
Part of the reason depression damages the cardiovascular system is inflammation. Between 21% and 34% of people with depression show elevated levels of C-reactive protein, a blood marker of systemic inflammation. They also tend to have higher levels of a signaling molecule called interleukin-6, which promotes inflammation throughout the body. Research published in The Lancet suggests that this inflammatory pathway isn’t just a side effect of depression; altered interleukin-6 activity may actually be a causal risk factor for developing depression in the first place.
This low-grade, persistent inflammation contributes to a cascade of physical problems. It accelerates the hardening of arteries, worsens insulin resistance, and may partly explain why depression so frequently co-occurs with conditions like heart disease, diabetes, and autoimmune disorders.
Depression Makes Other Illnesses Worse
People with diabetes are two to three times more likely to have depression than the general population. That combination is particularly dangerous because depression saps motivation, disrupts routines, and impairs the executive function needed to manage a complex chronic condition. Checking blood sugar, taking medications on schedule, exercising, and preparing appropriate meals all become harder when you can barely get out of bed.
The same pattern plays out across many chronic diseases. Depression worsens outcomes in heart failure, chronic pain, cancer, and respiratory disease. It does this both through behavioral pathways (people stop adhering to treatment plans) and biological ones (the stress hormones and inflammatory signals that accompany depression directly worsen these conditions). Treating depression in someone with a chronic illness often improves the other condition as well, which underscores how interconnected these problems are.
Suicide and Mortality
The most urgent reason depression demands attention is its connection to suicide. People with major depression are approximately 8.6 times more likely to die by suicide than the general population. Depression is present in the majority of suicide deaths worldwide, making it the single most important clinical risk factor.
Beyond suicide, depression is associated with higher mortality from other causes too, partly because of its effects on heart health, inflammation, and disease management described above. Taken together, depression shortens lives through multiple pathways at once.
The Economic Toll
Depression and anxiety together account for an estimated 12 billion lost working days every year globally, costing roughly $1 trillion annually in lost productivity. That figure reflects both absenteeism (missing work entirely) and presenteeism (showing up but functioning at a fraction of normal capacity). Presenteeism is actually the larger share, because many people with depression continue going to work while struggling with concentration, decision-making, and fatigue.
These costs ripple outward. Families lose income. Employers lose experienced workers. Healthcare systems absorb higher costs from the physical complications depression causes. In economic terms alone, depression is one of the most expensive health conditions in the world.
Treatment Works, but Gaps Remain
First-line treatments for depression, including therapy and medication, produce meaningful improvement in a substantial number of people. Response rates for initial medication treatment range from 40 to 60%, and full remission (a return to normal mood) occurs in 30 to 45% of cases. Those numbers improve further when people who don’t respond to a first approach switch strategies or combine therapies.
The critical point is that even partial response, a 50% reduction in symptoms, significantly changes a person’s ability to function, manage other health conditions, and avoid the worst outcomes. Full remission is the goal because lingering symptoms increase the risk of relapse, but any improvement matters. The gap between how many people could benefit from treatment and how many actually receive it remains one of the most significant failures in global healthcare. Closing that gap is precisely why understanding the importance of depression matters.